Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Radiology
|
July 1, 1998
Hypocalcemic stimulation and nonselective venous sampling for localizing parathyroid adenomas: work in progress
J L Doppman, M C Skarulis, R Chang, et al.
Cancer Research
|
January 19, 1999
In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)
P C Wu, H R Alexander, J Huang, et al.
Cytokine
|
July 6, 2000
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II)
A C Berger, H R Alexander, P C Wu, et al.
Surgery
|
December 1, 1995
Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas
K Amikura, H R Alexander, J A Norton, et al.
Cancer
|
September 18, 1998
A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis
D L Bartlett, J F Buell, S K Libutti, et al.
Surgery
|
December 17, 1998
Surgical treatment of localized gastrinoma within the liver: a prospective study
J A Norton, G M Doherty, D L Fraker, et al.
Surgery
|
December 17, 1998
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations
S K Libutti, P L Choyke, D L Bartlett, et al.
The Cancer Journal From Scientific American
|
May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma
G Y Ma, D L Bartlett, E Reed, et al.
Infection and Immunity
|
November 1, 1991
Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats
H R Alexander, G M Doherty, M I Block, et al.
The American Surgeon
|
November 1, 1995
High cervical intravagal hypercellular parathyroid gland as the etiology of severe persistent primary hyperparathyroidism
J F Buell, D L Fraker, J L Doppman, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Radiology
|
July 1, 1998
Hypocalcemic stimulation and nonselective venous sampling for localizing parathyroid adenomas: work in progress
J L Doppman, M C Skarulis, R Chang, et al.
Cancer Research
|
January 19, 1999
In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)
P C Wu, H R Alexander, J Huang, et al.
Cytokine
|
July 6, 2000
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II)
A C Berger, H R Alexander, P C Wu, et al.
Surgery
|
December 1, 1995
Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas
K Amikura, H R Alexander, J A Norton, et al.
Cancer
|
September 18, 1998
A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis
D L Bartlett, J F Buell, S K Libutti, et al.
Surgery
|
December 17, 1998
Surgical treatment of localized gastrinoma within the liver: a prospective study
J A Norton, G M Doherty, D L Fraker, et al.
Surgery
|
December 17, 1998
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations
S K Libutti, P L Choyke, D L Bartlett, et al.
The Cancer Journal From Scientific American
|
May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma
G Y Ma, D L Bartlett, E Reed, et al.
Infection and Immunity
|
November 1, 1991
Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats
H R Alexander, G M Doherty, M I Block, et al.
The American Surgeon
|
November 1, 1995
High cervical intravagal hypercellular parathyroid gland as the etiology of severe persistent primary hyperparathyroidism
J F Buell, D L Fraker, J L Doppman, et al.
Page
of 14